- Joined
- Jan 7, 2021
- Messages
- 16,097
Efficacy of Ivermectin on Disease Progression in Patients With COVID-19
This randomized clinical trial assesses the efficacy of ivermectin treatment in preventing progression to severe disease among high-risk patients with COVID-19 in Malaysia.
jamanetwork.com
Findings In this open-label randomized clinical trial of high-risk patients with COVID-19 in Malaysia, a 5-day course of oral ivermectin administered during the first week of illness did not reduce the risk of developing severe disease compared with standard of care alone.